Description Overview BPC-157 + TB-500 is a combination of two synthetic peptides widely studied in preclinical research: BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 fragment)
Personalized Treatment Regimen Dosage, frequency and program length are determined according to the provider-approved plan
BPC-157 tends to act more locally, while TB-500 supports broader, systemic repair
Clinically Proven Ingredients Science-backed medications and personalized treatments formulated with proven, clinically tested ingredients that meet the highest standards of safety and effectiveness
If you are on a very low dose and want maximum precision, a 50-unit or 30-unit syringe provides finer graduations
This pairing is typically positioned for laboratory work involving connective tissue pathways, repair signaling, and broader regenerative models where multiple recovery mechanisms are being evaluated together